<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01078272</url>
  </required_header>
  <id_info>
    <org_study_id>09-25</org_study_id>
    <nct_id>NCT01078272</nct_id>
  </id_info>
  <brief_title>The Saint Francis Remote Ischemic Preconditioning Trial (SaFR)</brief_title>
  <acronym>SaFR</acronym>
  <official_title>The Saint Francis Remote Ischemic Preconditioning Trial (SaFR)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>St. Francis Hospital, New York</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>St. Francis Hospital, New York</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study tests the hypothesis that repeated inflation of a blood pressure cuff on the arm
      will improve results of coronary stent implantation by:

        -  reducing chest pain and electrocardiogram changes during balloon inflation to place the
           stent

        -  reducing leakage of heart muscle protein(troponin) into the blood stream after stent
           placement, indicated reduced damage to heart muscle during stent implantation

        -  increases in molecules in the blood that promote dilation of arteries

        -  reduced evidence of heart muscle damage on MRI immediately after stenting

        -  improved patient outcomes over six months with fewer adverse cardiovascular events(heart
           attack, acute coronary syndrome,renarrowing of the stented artery, heart failure, death,
           stroke, transient ischemic attack)

        -  improved heart structure and function at 6 months after stenting
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>March 2010</start_date>
  <completion_date type="Anticipated">September 2011</completion_date>
  <primary_completion_date type="Anticipated">September 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Triple (Participant, Care Provider, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>MACE</measure>
    <time_frame>6 months post-stenting</time_frame>
    <description>MACE is defined as a combined endpoint including: heart attack, acute coronary syndrome,restenosis of the stented artery, new heart failure stroke, transient ischemic attack or death</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>troponin I</measure>
    <time_frame>24 hours</time_frame>
    <description>prevalence of cTn I &gt; 0.12 nG/ml in active RIPC and placebo groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>chest pain during stenting</measure>
    <time_frame>immediate during procedure</time_frame>
    <description>compare frequency, severity(1-10 scale) and duration of chest pain during stent implantation</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ST segment changes during stent implantation</measure>
    <time_frame>immediate</time_frame>
    <description>compare prevalence and severity of electrocardiographic ST segment elevation or depression during stent implantation between active and placebo groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MRI delayed enhancement</measure>
    <time_frame>1-7 days after stenting</time_frame>
    <description>Compare prevalence and volume of myocardial delayed gadolinium enhancement in active and placebo groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Late left ventricular volumes and ejection fraction</measure>
    <time_frame>6 months</time_frame>
    <description>Compare left ventricular ejection fraction, end-diastolic and end-systolic volumes between active and placebo groups at 6 months</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Coronary Artery Disease</condition>
  <arm_group>
    <arm_group_label>Remote Ischemic Preconditioning (RIPC)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Randomized subjects who are treated immediately prior to stenting with remote ischemic preconditioning consisting of 3 5 minute blood pressure cuff inflations to occlude the brachial artery in their nondominant arms, with intervening 5 minute rest periods.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Sham Remote Ischemic Preconditioning</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Patients who prior to stenting have the RIPC blood pressure cuff placed but not inflated for 3 5 minute episodes with 5 minute rest periods.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Remote ischemic preconditioning</intervention_name>
    <description>Randomized subjects are treated immediately prior to stenting with remote ischemic preconditioning consisting of 3 5 minute blood pressure cuff inflations to occlude the brachial artery in their nondominant arms, with intervening 5 minute rest periods.</description>
    <arm_group_label>Remote Ischemic Preconditioning (RIPC)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sham Remote Ischemic Preconditioning</intervention_name>
    <description>Randomized subjects who are exposed immediately prior to stenting to sham remote ischemic preconditioning consisting of 3 5 minute blood pressure cuff placements without inflation on their nondominant arms, with intervening 5 minute rest periods.</description>
    <arm_group_label>Sham Remote Ischemic Preconditioning</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with stable chronic coronary artery disease scheduled for elective
             percutaneous intervention.

        Exclusion Criteria:

          -  Recent (1 month) myocardial infarction

          -  Acute coronary syndrome

          -  Chest pain at res

          -  Estimated glomerular filtration rate(GFR)&lt;45 mL/min/1.73 m2

          -  Frequent premature atrial or ventricular contractions or atrial fibrillation

          -  Any contraindication to MRI including implanted non MRI compatible medical devices or
             ferromagnetic materials such as shrapnel

          -  Inability to breath-hold

          -  Severe claustrophobia

          -  Deafness

          -  Persistent tremor

          -  Inability to follow instructions.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>40 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Nathaniel Reichek, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Francis Hospital-The Heart Center, Roslyn, NY</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elizabeth Haag, RN CCRP</last_name>
    <phone>5165626790</phone>
    <email>Elizabeth.Haag@chsli.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lyn Santiago, RN CCRC</last_name>
    <phone>5165626763</phone>
    <email>Lyn.Santiago@chsli.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>St. Francis Hospital-The Heart Center</name>
      <address>
        <city>Roslyn</city>
        <state>New York</state>
        <zip>11576</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <investigator>
      <last_name>Nathaniel Reichek, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Richard Shlofmitz, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jie (Jane) Cao, MD, MPH</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Madhavi Kadiyala, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/19188504?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&amp;ordinalpos=39</url>
    <description>First randomized trial of RIPC for coronary stenting</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/19221230?itool=EntrezSystem2.PEntrez.Pubmed.Pubmed_ResultsPanel.Pubmed_RVDocSum&amp;ordinalpos=37</url>
    <description>editorial review of remote ischemic preconditioning in coronary disease</description>
  </link>
  <link>
    <url>http://www.thelancet.com/journals/lancet/issue/vol375no9716/PIIS0140-6736(10)X6115-3</url>
    <description>Lancet, trial of RIPC in acute myocardial infarction</description>
  </link>
  <verification_date>February 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 1, 2010</study_first_submitted>
  <study_first_submitted_qc>March 1, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 2, 2010</study_first_posted>
  <last_update_submitted>March 1, 2010</last_update_submitted>
  <last_update_submitted_qc>March 1, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 2, 2010</last_update_posted>
  <responsible_party>
    <name_title>Nathaniel Reichek MD, FACC, FAHA Director, Research Department, Director, Cardiac Imaging, St. Francis Hospital</name_title>
    <organization>St. Francis Hospital-The Heart Center, Roslyn, NY</organization>
  </responsible_party>
  <keyword>Coronary Atherosclerosis</keyword>
  <keyword>Percutaneous Coronary Intervention</keyword>
  <keyword>Coronary Stenting</keyword>
  <keyword>Coronary Stenosis</keyword>
  <keyword>Remote Ischemic Preconditioning</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

